Grants and Contributions:
Title:
Augmentation for Cardiovascular Disease in Lung Cancer Patients
Agreement Number:
956074
Agreement Value:
$45,000.00
Agreement Date:
Sep 8, 2020 - May 31, 2021
Description:
Altis Labs is creating a cardiac mortality risk score from patient chest CTs to increase awareness of patient’s risk of cardiovascular death. Cardiovascular death is the second highest cause of death in patients diagnosed with cancer
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M4Y 0C4
Reference Number:
172-2020-2021-Q2-956074
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
703643080
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 75 days. The total amended value is -8,000 dollars.
Amendment Date
Jan 18, 2021
Recipient's Operating Name:
Altis Labs
Recipient's Legal Name:
Altis Labs, Inc
Federal Riding Name:
Toronto Centre
Federal Riding Number:
35108
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: